PubRank

Jennifer P Morton

Author PubWeight™ 31.14‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 A complex secretory program orchestrated by the inflammasome controls paracrine senescence. Nat Cell Biol 2013 2.98
2 Activation of the PIK3CA/AKT pathway suppresses senescence induced by an activated RAS oncogene to promote tumorigenesis. Mol Cell 2011 2.40
3 P-Rex1 is required for efficient melanoblast migration and melanoma metastasis. Nat Commun 2011 2.18
4 Autophagic targeting of Src promotes cancer cell survival following reduced FAK signalling. Nat Cell Biol 2011 2.07
5 Rab25 and CLIC3 collaborate to promote integrin recycling from late endosomes/lysosomes and drive cancer progression. Dev Cell 2011 1.87
6 p53 mutation and loss have different effects on tumourigenesis in a novel mouse model of pleomorphic rhabdomyosarcoma. J Pathol 2010 1.79
7 Focal adhesion kinase is required for intestinal regeneration and tumorigenesis downstream of Wnt/c-Myc signaling. Dev Cell 2010 1.79
8 p53 represses RNA polymerase III transcription by targeting TBP and inhibiting promoter occupancy by TFIIIB. EMBO J 2003 1.68
9 MicroRNA molecular profiles associated with diagnosis, clinicopathologic criteria, and overall survival in patients with resectable pancreatic ductal adenocarcinoma. Clin Cancer Res 2011 1.57
10 Spatial regulation of RhoA activity during pancreatic cancer cell invasion driven by mutant p53. Cancer Res 2011 1.44
11 Mutant p53-associated myosin-X upregulation promotes breast cancer invasion and metastasis. J Clin Invest 2014 1.33
12 CK2 forms a stable complex with TFIIIB and activates RNA polymerase III transcription in human cells. Mol Cell Biol 2002 1.21
13 Activation of the IL-6R/Jak/stat pathway is associated with a poor outcome in resected pancreatic ductal adenocarcinoma. J Gastrointest Surg 2013 1.15
14 Deregulation of RNA polymerase III transcription in cervical epithelium in response to high-risk human papillomavirus. Oncogene 2005 1.00
15 Intravital FLIM-FRET imaging reveals dasatinib-induced spatial control of src in pancreatic cancer. Cancer Res 2013 0.99
16 Dasatinib inhibits mammary tumour development in a genetically engineered mouse model. J Pathol 2013 0.86
17 FLIM-FRET imaging in vivo reveals 3D-environment spatially regulates RhoGTPase activity during cancer cell invasion. Small GTPases 2011 0.84
18 Ras, PI3K/Akt and senescence: Paradoxes provide clues for pancreatic cancer therapy. Small GTPases 2011 0.79
19 Monitoring the dynamics of Src activity in response to anti-invasive dasatinib treatment at a subcellular level using dual intravital imaging. Cell Adh Migr 2014 0.78
20 Timing is everything: Brca2 and p53 mutations in pancreatic cancer. Gastroenterology 2011 0.77
21 Advanced intravital subcellular imaging reveals vital three-dimensional signalling events driving cancer cell behaviour and drug responses in live tissue. FEBS J 2013 0.77
22 The right time, the right place: will targeting human cancer-associated mutations to the mouse provide the perfect preclinical model? Curr Opin Genet Dev 2012 0.77
23 A FAK-PI-3K-mTOR axis is required for Wnt-Myc driven intestinal regeneration and tumorigenesis. Cell Cycle 2011 0.77